276 related articles for article (PubMed ID: 25848225)
1. Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M.
Pradeepkiran JA; Kumar KK; Kumar YN; Bhaskar M
Drug Des Devel Ther; 2015; 9():1897-912. PubMed ID: 25848225
[TBL] [Abstract][Full Text] [Related]
2. Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M.
Pradeepkiran JA; Sainath SB; Kumar KK; Bhaskar M
Drug Des Devel Ther; 2015; 9():1691-706. PubMed ID: 25834405
[TBL] [Abstract][Full Text] [Related]
3. Identification of Phosphoribosyl-AMP cyclohydrolase, as drug target and its inhibitors in Brucella melitensis bv. 1 16M using metabolic pathway analysis.
Gupta M; Prasad Y; Sharma SK; Jain CK
J Biomol Struct Dyn; 2017 Feb; 35(2):287-299. PubMed ID: 26725317
[TBL] [Abstract][Full Text] [Related]
4. A Bacteriophage Capsid Protein Is an Inhibitor of a Conserved Transcription Terminator of Various Bacterial Pathogens.
Ghosh G; Reddy J; Sambhare S; Sen R
J Bacteriol; 2018 Jan; 200(1):. PubMed ID: 29038252
[TBL] [Abstract][Full Text] [Related]
5. Modeling, molecular docking, probing catalytic binding mode of acetyl-CoA malate synthase G in
Adi PJ; Yellapu NK; Matcha B
Biochem Biophys Rep; 2016 Dec; 8():192-199. PubMed ID: 28955956
[TBL] [Abstract][Full Text] [Related]
6. A multicopper oxidase contributes to the copper tolerance of Brucella melitensis 16M.
Wu T; Wang S; Wang Z; Peng X; Lu Y; Wu Q
FEMS Microbiol Lett; 2015 Jun; 362(12):fnv078. PubMed ID: 25956175
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
[TBL] [Abstract][Full Text] [Related]
8. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.
Verma P; Tiwari M; Tiwari V
J Biomol Struct Dyn; 2018 Apr; 36(5):1182-1194. PubMed ID: 28393677
[TBL] [Abstract][Full Text] [Related]
9. Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation.
Raj KK; Ganesh Kumar V; Leela Madhuri C; Mathi P; Durga Lakshmi R; Ravi M; Sri Ramudu B; Venkata Rao SV; Ramachandran D
J Mol Graph Model; 2015 Jul; 60():89-97. PubMed ID: 26119984
[TBL] [Abstract][Full Text] [Related]
10. Molecular Docking and
Muhammad I; Niaz S; Gul E Nayab ; Hussain A; Ahmad S; Rahman N; Khan H; Ali A
Curr Comput Aided Drug Des; 2021; 17(7):946-956. PubMed ID: 32532195
[TBL] [Abstract][Full Text] [Related]
11. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
Uba AI; Yelekçi K
Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
[TBL] [Abstract][Full Text] [Related]
12. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study.
Pradhan D; Priyadarshini V; Munikumar M; Swargam S; Umamaheswari A; Bitla A
J Biomol Struct Dyn; 2014; 32(2):171-85. PubMed ID: 23383626
[TBL] [Abstract][Full Text] [Related]
13. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis.
Valdezate S; Navarro A; Medina-Pascual MJ; Carrasco G; Saéz-Nieto JA
J Antimicrob Chemother; 2010 Jan; 65(1):51-3. PubMed ID: 19861338
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteome analysis of laboratory grown Brucella abortus 2308 and Brucella melitensis 16M.
Eschenbrenner M; Horn TA; Wagner MA; Mujer CV; Miller-Scandle TL; DelVecchio VG
J Proteome Res; 2006 Jul; 5(7):1731-40. PubMed ID: 16823981
[TBL] [Abstract][Full Text] [Related]
15. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
16. Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host.
Zygmunt MS; Hagius SD; Walker JV; Elzer PH
Microbes Infect; 2006; 8(14-15):2849-54. PubMed ID: 17090391
[TBL] [Abstract][Full Text] [Related]
17. Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis.
Ojo KK; Ranade RM; Zhang Z; Dranow DM; Myers JB; Choi R; Nakazawa Hewitt S; Edwards TE; Davies DR; Lorimer D; Boyle SM; Barrett LK; Buckner FS; Fan E; Van Voorhis WC
PLoS One; 2016; 11(8):e0160350. PubMed ID: 27500735
[TBL] [Abstract][Full Text] [Related]
18. Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach.
Rowaiye AB; Ogugua AJ; Ibeanu G; Bur D; Asala MT; Ogbeide OB; Abraham EO; Usman HB
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0009799. PubMed ID: 35312681
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the virulence of a Brucella melitensis hemagglutinin gene in the caprine model.
Perry QL; Hagius SD; Walker JV; Elzer PH
Vaccine; 2010 Oct; 28 Suppl 5():F6-11. PubMed ID: 20362205
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis for the mode of action of bicyclomycin.
Kohn H; Widger W
Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
